4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fusen Pharmaceutical Company Limited (1652) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Nanyang, China with about 1,005 employees. Its market capitalization is roughly CNY 784 million. In the fiscal year ended 2025-12-31, 1652 reported CNY 273M in revenue and (CNY 12M) in net income.
Fusen Pharmaceutical Company Limited, an investment holding company, engages in the manufacturing and sale of pharmaceutical products in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 273M | CNY 326M | CNY 566M | CNY 492M | — |
| Gross Profit | CNY 110M | CNY 163M | CNY 300M | CNY 225M | — |
| Operating Income (EBIT) | CNY 14M | (CNY 58M) | CNY 28M | CNY 39M | — |
| Net Income | (CNY 12M) | (CNY 189M) | (CNY 36M) | (CNY 35M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | (CNY 7M) | (CNY 8M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.2B | CNY 1.3B | CNY 1.4B | — |
| Total Liabilities | CNY 906M | CNY 870M | CNY 782M | CNY 737M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1652 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms